13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 88 holding rows worth $2,984,124,707.
- Accession
- 0001420506-23-000696
- Filer
- CIK 1920938
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 90 entries on the cover page, a total value of $2,984,124,707 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,984,124,707 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 250,022,000 | $156,738,792 | dollars as filed | principal |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 145,520,000 | $118,195,691 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 131,834,000 | $117,582,745 | dollars as filed | principal |
| EXACT SCIENCES CORP | 30063PAC9 | NOTE 0.375% 3/0 | 139,000,000 | $109,643,200 | dollars as filed | principal |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 112,250,000 | $103,135,300 | dollars as filed | principal |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 109,251,000 | $100,237,793 | dollars as filed | principal |
| GLAUKOS CORP COM | 377322102 | Stock | 1,661,851 | $72,589,652 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 3,341,300 | $71,537,233 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 252,542 | $69,933,931 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,362,278 | $65,321,230 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 1,621,012 | $65,116,052 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 141,500,000 | $63,675,000 | dollars as filed | principal |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 3,469,674 | $63,495,034 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,548,110 | $61,041,977 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 223,120 | $59,204,892 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 3,271,513 | $53,620,098 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 65,976,000 | $49,369,841 | dollars as filed | principal |
| IONIS PHARMACEUTICALS INC | 462222AD2 | NOTE 4/0 | 52,740,000 | $48,949,313 | dollars as filed | principal |
| NEVRO CORP | 64157F103 | COM | 1,192,298 | $47,215,001 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 50,536,000 | $46,649,782 | dollars as filed | principal |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 497,667 | $46,616,468 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 219,930 | $46,383,237 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 1,704,552 | $44,011,533 | dollars as filed | |
| AMYRIS INC | 03236MAJ0 | BOND | 137,850,000 | $43,250,438 | dollars as filed | principal |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,044,699 | $41,505,891 | dollars as filed | |
| EXACT SCIENCES CORP | 30063PAB1 | NOTE 0.375% 3/1 | 48,300,000 | $40,089,000 | dollars as filed | principal |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,393,985 | $37,705,264 | dollars as filed | |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 399,630,000 | $37,665,128 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 43,000,000 | $36,469,375 | dollars as filed | principal |
| PENUMBRA INC COM | 70975L107 | Stock | 162,828 | $36,222,717 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 131,100 | $34,432,104 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 4,112,494 | $33,804,701 | dollars as filed | |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 36,533,000 | $33,358,282 | dollars as filed | principal |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 658,101 | $32,852,402 | dollars as filed | |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 36,665,000 | $32,210,203 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 48,678,000 | $31,947,371 | dollars as filed | principal |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,242,802 | $31,629,311 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,998,084 | $30,910,360 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,455,585 | $30,610,953 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 31,350,000 | $28,685,250 | dollars as filed | principal |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 358,056 | $28,365,196 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,620,216 | $27,106,214 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,246,539 | $26,825,519 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 839,075 | $26,179,140 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 300,437 | $25,738,438 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 343,626 | $25,521,103 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,493,121 | $23,770,486 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 726,122 | $22,502,521 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 416,817 | $22,028,779 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 3,393,405 | $21,140,913 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAK7 | NOTE 1.250% 5/1 | 19,200,000 | $20,727,568 | dollars as filed | principal |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 389,596 | $20,146,009 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,000,000 | $19,800,000 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 413,600 | $18,740,216 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 303,185 | $18,712,578 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 49,200 | $18,638,436 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 12,107,785 | $18,524,911 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 140,352 | $18,186,812 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 662,349 | $18,015,893 | dollars as filed | |
| STERIS PLC SHS USD | G8473T100 | Stock | 95,694 | $17,673,725 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 235,319 | $17,557,151 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 3,474,497 | $17,233,505 | dollars as filed | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 52,115 | $17,232,867 | dollars as filed | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 21,500,000 | $17,038,830 | dollars as filed | principal |
| NUVASIVE INC | 670704AL9 | BOND | 16,500,000 | $16,231,875 | dollars as filed | principal |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 42,294,000 | $16,151,021 | dollars as filed | principal |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 325,838 | $15,157,984 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,621,494 | $13,669,194 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,862,700 | $10,915,422 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,250,052 | $10,887,953 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 927,800 | $10,122,298 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAH4 | NOTE 0.599% 8/0 | 9,000,000 | $9,574,200 | dollars as filed | principal |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 313,403 | $9,154,502 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,525,800 | $9,139,542 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,814,266 | $9,125,758 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 753,145 | $8,728,951 | dollars as filed | |
| INSMED INC | 457669AB5 | NOTE 0.750% 6/0 | 10,000,000 | $8,300,000 | dollars as filed | principal |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,122,900 | $7,915,968 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 920,304 | $7,748,960 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 725,024 | $6,691,972 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 914,209 | $6,545,736 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 6,500,000 | $6,418,750 | dollars as filed | principal |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 2,000,000 | $6,300,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,164,849 | $4,612,802 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 381,120 | $4,001,760 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 258,280 | $2,910,816 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 620,280 | $1,401,833 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 71,585 | $1,398,055 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000696 | this filing | 2023-02-14 | acceptance time not in the bulk data set |